Connection

Elizabeth Garrett-Mayer to Pharmacogenetics

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Pharmacogenetics.
Elizabeth Garrett-Mayer
Connection Strength
0.392
Pharmacogenetics
  1. Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia. Blood. 2012 Jan 05; 119(1):55-63.
    View in: PubMed
    Score: 0.366
  2. Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):135-43.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.